The first test to identify acute mountain sickness has been developed by a team of researchers in Italy and France and is presented today at EuroEcho-Imaging 2013. The test could revolutionise trekking and climbing by predicting ...
Dec 12, 2013
0
0
A cardiovascular disease (CVD) expert is calling for mandatory screening of 18 year-old Mexicans to halt the CVD epidemic plaguing the nation. Cardiovascular risk factors will be a key theme at the Mexican Congress of Cardiology, ...
Nov 23, 2013
0
0
Psychological interventions halve deaths and cardiovascular events in heart disease patients, according to research from Athens, Greece, presented at the Acute Cardiac Care Congress 2013.
Oct 12, 2013
0
0
(HealthDay)—Colchicine is more effective than placebo in reducing the risk of incessant or recurrent pericarditis in patients with acute pericarditis, according to a study published online Sept. 1 in the New England Journal ...
Sep 4, 2013
0
0
(HealthDay)—Patients with heart valve replacements have greater rates of thromboembolic and bleeding complications after treatment with dabigatran compared with warfarin, according to a study published online Sept. 1 in ...
Sep 4, 2013
0
0
Patients with clogged and hardened arteries who already have their blood pressure under control may benefit from an additional blood pressure-lowering medication, according to research from the Cleveland Clinic Coordinating ...
Sep 3, 2013
0
0
A smart phone app could help doctors more easily identify patients who are at risk of dying within three years a heart attack.
Sep 3, 2013
0
0
A long-term study of children with a complex heart condition called hypertrophic cardiomyopathy (HCM) found that the risk of death or need for immediate listing for heart transplantation was greatest for those who developed ...
Sep 3, 2013
0
0
The blood pressure lowering drug aliskiren did not improve coronary artery disease when given to patients who had prehypertension, results of the Aliskiren Quantitative Atherosclerosis Regression Intravascular Ultrasound ...
Sep 3, 2013
0
0
Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with unfractionated heparin plus eptifibatide but increased bleeding among patients with non–ST-segment elevation acute coronary syndromes ...
Sep 1, 2013
0
0
